Breaking News
Close
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Cannabis Stocks Show Impressive First Quarter Gains  

By Investing.com (Brenda O'Farrell/Investing.com)Stock MarketsApr 06, 2021 11:28
uk.investing.com/analysis/cannabis-stocks-show-impressive-first-quarter-gains-200467286
Cannabis Stocks Show Impressive First Quarter Gains  
By Investing.com (Brenda O'Farrell/Investing.com)   |  Apr 06, 2021 11:28
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Canadian cannabis stocks are being given some of the credit for propelling the Toronto Stock Exchange, the country’s main stock index, to posting an impressive gain in the first quarter of 2021.

The TSX reported a 7.37% uptick in the first quarter of the year, propelling it to rank 34th among the 92 global market indexes. This gain is due, in large part, to the performance of the exchange’s health care subsector, which saw an almost 40% surge in the first quarter. This drive upward was fuelled largely by cannabis stocks that benefited from increasingly positive signs of the growing list of US markets moving to legalize the weed.

The two top performing stocks on the TSX in the first quarter were cannabis companies Aphria (TSX:APHA) (NASDAQ:APHA) and OrganiGram (TSX:OGI) (NASDAQ:OGI).

APHA Daily
APHA Daily

Aphria, which closed up slightly on Monday at $22.79 on the TSX and posted a less-than-half-percent increase for the day on the NASDAQ in New York, has gained more than 160% in the first quarter of 2021. In the last year, the marijuana grower has seen its increase by 542% on the New York exchange. It had a slightly less spectacular showing in Canada, where its shares on the TSX in the last year gained 474%

Part of the reason Aphria shares have done so well has been its execution on its plans to expand, striking a deal to acquire another Canadian-based cannabis company, Tilray (NASDAQ:TLRY). The deal, which was announced towards the end of 2020, is on track to be completed later this month. The new combined company will operate under the Tilray name. It is estimated that it will control roughly a fifth of the cannabis market in Canada. 

And with plans to expand in the US, where legalization continues to march forward, the stock appears poised to continue its upward trajectory. According to Toronto's Globe and Mail, nine out of 15 analysts peg it as a strong or moderate buy.

As for Organigram, its shares gained almost a full percentage point yesterday on the TSX to close at C$4.36 and 1.45% to end the day Monday at US$3.49 on the NASDAQ. The Canadian-traded shares gained almost 157% in the first quarter. In the last year, they have added just over 91% on the TSX, while US-traded shares have surged just over 115% in the last 12 months.

OGI Daily
OGI Daily

Like Aphria, Organigram is poised to be a player in the growing US market, with British American Tobacco (NYSE:BTI) scooping up an almost 20% stake in the company last month.

Together, Organigram and BAT plan to build a research facility to develop what they are calling “next-generation cannabis products.”

Cannabis Stocks Show Impressive First Quarter Gains  
 

Related Articles

Cannabis Stocks Show Impressive First Quarter Gains  

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email